Concepedia

Christian K. Tikkanen

CK

8

Publications

130

Citations

8

H-Index

2015

Active since

Affiliations

Novo Nordisk (Denmark)(Current)

Slagelse Hospital

University of Southern Denmark

Novo Nordisk (United Kingdom)

Christian K. Tikkanen is an author at Novo Nordisk (Denmark) specializing in medical laboratory science, global health, and health sciences.

ORCID

Top concepts

Publications per year

2015–2023

8

Publications

8

Management of Patients with Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide, Exenatide ER, Liraglutide and Lixisenatide: A Cost-Effectiveness Analysis in the Danish Setting

Peter Gæde, Pierre Johansen, Christian K. Tikkanen et al. · Diabetes Therapy · 2019 · 30 citations · Full text

A short-term cost-utility analysis of insulin degludec versus insulin glargine U100 in patients with type 1 or type 2 diabetes in Denmark

Richard F. Pollock, Christian K. Tikkanen · Journal of Medical Economics · 2016 · 20 citations

Real‐world impact of once‐weekly subcutaneous semaglutide after 2 years of follow‐up: Results from a nationwide observational study in people with type 2 diabetes

Tina Vilsbøll, Caroline Ø. Lindahl, NICK F. NIELSEN et al. · Diabetes Obesity and Metabolism · 2023 · 19 citations · Full text

The Cost of Non-Severe Hypoglycaemia In Europe

Barrie Chubb, Christian K. Tikkanen · Value in Health · 2015 · 15 citations

, , +6

The economic burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in Denmark

Asger Lindvig, Martin Tran, Robert S. Kidd et al. · Current Medical Research and Opinion · 2021 · 15 citations

Rows per page

1–5 of 8